Abstract
The treatment landscape is rapidly evolving for relapsed/refractory follicular lymphoma (r/r FL); however, prognostic factors and effect modifiers in later line settings in FL have not been assessed systematically. This systematic literature review (SLR) was conducted to identify prognostic factors and effect modifiers in adult patients with r/r FL who failed at least 2 prior lines of therapy (3L+).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have